KMS Medisurgi Ltd
₹0.00▲ +0.00 (+0.00%)
KMSMEDISURGILTD·NSE·Healthcare
Market Cap
43.80 Cr
PE Ratio
179.50
Volume
—
Day High - Low
—
52W High-Low
132.80 - 126.50
₹0.00▲ +0.00 (+0.00%)
Market Cap43.80 Cr
PE Ratio179.50
Volume—
Day High - Low—
52W High-Low132.80 - 126.50
KMS Medisurgi Ltd (KMSMEDISURGILTD): company summary
KMS Medisurgi Ltd (KMSMEDISURGILTD) is a micro-cap Healthcare company valued at ₹44 crore operating in Medical Equipment on the NSE and BSE.
KMS Medisurgi Ltd (KMSMEDISURGILTD) is a micro-cap Healthcare company valued at ₹44 crore operating in Medical Equipment on the NSE and BSE.
- Financial performance
- Revenue has been growing slowly at 3.5% a year over three years; profit fell 24.0% a year, behind revenue — margins are under pressure. Return on equity is 3.0%.
- Valuation multiples
- The stock trades at 179.5 times earnings, a premium to the Healthcare median of 32.0, 5.27 times book value. It yields 0.0%.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
4.3/10
Weak
Fair Value
Sign in to see
ROE
3.05%
Weak
P/E
179.50x
Expensive
Debt / Equity
0.09
Low
Industry
Healthcare
Medical Equipment
Overall View
Weak
Price performance
52W₹126.50
₹132.80
DocStoX take
Supported by growth (7.1), but held back by valuation (0.0). Scored on 4 of 5 measures.
DocStoX score
Medium confidence4.3
/10
Weak
Quality
Modest
ROE 3.0%
Valuation
Expensive
P/E 179.5×
Growth
Steady
Revenue +10.2% 5Y CAGR
Risk
Moderate
D/E 0.09
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹44 Cr
52W High / Low
₹133 / ₹127
Dividend Yield
0.04%
Promoter Holding
74.42%
EPS (TTM)
₹1.33
Book Value
₹25.18
Key highlights
- Low leverage — D/E 0.09
- Profitable in all of the last 5 years
- Profit compounding 16% a year
- Valuation is weak (0.0/10)
- Expensive at 180× earnings
3 Positives3 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Medical Equipment
Explore KMS Medisurgi Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
KMS Medisurgi Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedLaurus Labs LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare KMS Medisurgi Ltd with peers
KMS Medisurgi Ltd vs Sun Pharmaceutical Industries LimitedKMS Medisurgi Ltd vs Divi's Laboratories LimitedKMS Medisurgi Ltd vs Torrent Pharmaceuticals LimitedKMS Medisurgi Ltd vs Apollo Hospitals Enterprise LimitedKMS Medisurgi Ltd vs Zydus Lifesciences LimitedKMS Medisurgi Ltd vs Laurus Labs Limited
Related tools & concepts
Value KMS Medisurgi Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing